10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Balantidium coli is a ciliated protozoan parasite known to infect the gastrointestinal tract of humans. While pigs serve as the primary reservoir host, humans can acquire the infection through the ingestion of contaminated food or water containing cysts of the parasite. Once ingested, the cysts transform into trophozoites in the colon, causing a condition known as balantidiasis. Common symptoms include diarrhea, abdominal pain, nausea, and fever. Severe cases may lead to dysentery and perforation of the intestinal wall, posing significant health risks. Diagnosis of Balantidium coli infections involves the identification of cysts or trophozoites in stool samples. Treatment typically involves antimicrobial medications, such as metronidazole or tetracycline. However, cases of resistance to these drugs have been reported, underscoring the importance of tailored treatment regimens and close medical supervision. Prevention measures focus on maintaining proper hygiene, ensuring the thorough cooking of food, and practicing safe water consumption, especially in areas with a higher prevalence of balantidiasis.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria